Churg-Strauss syndrome;Syndrome de churg et strauss

Revue du Praticien

Volumn 58, Issue 11, 2008, Pages 1165-1174

  Lhote, François ^a   Cohen, Pascal ^b   Gullpain, Philippe ^b   Guillevin, Loïc ^b  

^a Centre Hospitalier de Saint Denis   (France)

^b Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD69 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FAS ANTIGEN; FLUTICASONE PROPIONATE PLUS SALMETEROL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MESNA; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; ZAFIRLUKAST; ZILEUTON;

ASTHMA; CHURG STRAUSS SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPEREOSINOPHILIA; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; PATHOPHYSIOLOGY; REVIEW; TREATMENT INDICATION;

CHURG-STRAUSS SYNDROME; HUMANS; PROGNOSIS;

EID: 47249115228     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a french urban multiethnic population in 2000 : a capture-recapture estimate. Arthritis Rheum 2004;51:92-9.
2. Martin RM, Wilton LV, Mann RD. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf 1999;8:179-189.
3. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999;78:26-37.
4. Louthrenoo W, Norasetthada A, Khunamornpong S, Sreshthaputra A, Sukitawut W. Childhood Churg-Strauss syndrome. J Rheumatol 1999; 26:1387-93.
5. Lhote F, Cohen P, Chemlal K, Jarrousse B, Guillevin L. Les manifestations pleurales au cours de la périartérite noueuse, de la maladie de Wegener et du lupus érythémateux systémique. Ann Med Interne 1992; 143:228-32.
6. Guillevin L, Lhote F, Casassus P, Cohen P, Jarrousse B, Lortholary O. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine 1996;75:17-28.
7. Lie JT. Limited forms of Churg-Strauss syndrome. Pathology Annual 1993;28:199-220.
8. Sablé-Fourtassou R, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632-8.
9. Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss ssyndrome. Arthritis Rheum 2005;52:2926-35.
10. Hellmich B, Ehlers S, Csernok E, Gross WL. Update on the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol 2003;21:S69-S77.
11. Phanuphak P, Kohler PF. Onset of polyarteritis nodosa during allergic hyposensitization treatment. Am J Med 1980;68:479-85.
12. Lhote F. Vascularites systémiques au cours de parasitoses. Presse Med 2004;33:1389-401.
13. Weller PF, Plaut M, Taggart V, Trontell A. The relationship of astma therapy and Churg-Strauss syndrome : NIH workshop summary report. Allergy Clin Immunol 2001;108:175-83.
14. Katzenstein AL. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. Am J Clin Pathol 2000;114:767-72.
15. Keogh KA, Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003;115:284-90.
16. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984;63:65-81.
17. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis angiitis). Arthritis Rheum 1990;33:1094-100.
18. Luqmani R, Exley A, Kitas G, Bacon P. Disease assessment and management of the vasculitides. Clin Rheumatol 1997;11:424-46.
19. Guillevin L, Mahr A, Cohen P. Les vascularis nécrosantes systémiques: classification et stratégies actuelles de traitement. Rev Med Interne 2003;24:172-82.
20. Langford CA, Talar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004;51:278-83.
21. Lhote F, Guillevin L. Indications of plasma exchanges in the treatment of polyarteritis nodosa, Churg-Strauss syndrome and other systemic vasculitides. Transfus Sci 1996;17:211-3.